The role of NF-κB in PPARα-mediated hepatocarcinogenesis

PPAR Research

Volumn , Issue , 2008, Pages

  Glauert, Howard P ^a   Calfee Mason, Karen ^b   Li, Yixin ^c   Nilakantan, Vani ^d   Twaroski, Michelle L ^e   Tharappel, Job ^a   Spear, Brett T ^f  

^a UNIVERSITY OF KENTUCKY   (United States)

^b WESTERN KENTUCKY UNIVERSITY   (United States)

^c APPLIED BIOSYSTEMS   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFIBRATE; DICAMBA; GEMFIBROZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAFENOPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PHTHALIC ACID DIBUTYL ESTER; PIRINIXIC ACID; PIRINIXIL; PROTEIN P50;

APOPTOSIS; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; HUMAN; INHIBITION KINETICS; LIVER; LIVER CARCINOGENESIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA BINDING; REVIEW;

EID: 60049098383     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/286249     Document Type: Review

References (74)

1. Rao M. S., Reddy J. K., Peroxisome proliferation and hepatocarcinogenesis Carcinogenesis 1987 8 5 631 636
2. Cattley R. C., DeLuca J., Elcombe C., Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regulatory Toxicology and Pharmacology 1998 27 1 47 60
3. Peters J. M., Cattley R. C., Gonzalez F. J., Role of PPAR α in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 1997 18 11 2029 2033
4. Schoonjans K., Staels B., Auwerx J., Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression Journal of Lipid Research 1996 37 5 907 925
5. Eacho P. I., Feller D. R., Witiak D. T., Newman H. A. I., Feller D. R., Hepatic peroxisome proliferation induced by hypolipidemic drugs and other chemicals Antilipidemic Drugs, Medicinal, Chemical and Biochemical Aspects 1991 Amsterdam, The Netherlands Elsevier Science 375 426
6. Lock E. A., Mitchell A. M., Elcombe C. R., Biochemical mechanisms of induction of hepatic peroxisome proliferation Annual Review of Pharmacology and Toxicology 1989 29 145 163
7. O'Brien M. L., Spear B. T., Glauert H. P., Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis Critical Reviews in Toxicology 2005 35 1 61 88
8. Karin M., Lin A., NF- κB at the crossroads of life and death Nature Immunology 2002 3 3 221 227
9. Karin M., Delhase M., The I κB kinase (IKK) and NF- κB: key elements of proinflammatory signalling Seminars in Immunology 2000 12 1 85 98
10. Zandi E., Rothwarf D. M., Delhase M., Hayakawa M., Karin M., The I κB kinase complex (IKK) contains two kinase subunits, IKK α and IKK β, necessary for I κB phosphorylation and NF- κB activation Cell 1997 91 2 243 252
11. Karin M., NF- κB and cancer: mechanisms and targets Molecular Carcinogenesis 2006 45 6 355 361
12. Staal F. J. T., Roederer M., Herzenberg L. A., Herzenberg L. A., Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus Proceedings of the National Academy of Sciences of the United States of America 1990 87 24 9943 9947
13. Schreck R., Rieber P., Baeuerle P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF- κB transcription factor and HIV-1 The EMBO Journal 1991 10 8 2247 2258
14. Schreck R., Albermann K., Baeuerle P. A., Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review) Free Radical Research Communications 1992 17 4 221 237
15. Meyer M., Schreck R., Baeuerle P. A., H 2 O 2 and antioxidants have opposite effects on activation of NF- κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor The EMBO Journal 1993 12 5 2005 2015
16. Nilakantan V., Spear B. T., Glauert H. P., Liver-specific catalase expression in transgenic mice inhibits NF- κB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate Carcinogenesis 1998 19 4 631 637
17. Calfee-Mason K. G., Spear B. T., Glauert H. P., Effects of vitamin E on the NF- κB pathway in rats treated with the peroxisome proliferator, ciprofibrate Toxicology and Applied Pharmacology 2004 199 1 1 9
18. Li Y., Glauert H. P., Spear B. T., Activation of nuclear factor- κB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N -acetylcysteine and vitamin E Biochemical Pharmacology 2000 59 4 427 434
19. Schmidt K. N., Amstad P., Cerutti P., Baeuerle P. A., The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF- κB Chemistry & Biology 1995 2 1 13 22
20. Hayakawa M., Miyashita H., Sakamoto I., Evidence that reactive oxygen species do not mediate NF- κB activation The EMBO Journal 2003 22 13 3356 3366
21. FitzGerald M. J., Webber E. M., Donovan J. R., Fausto N., Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration Cell Growth & Differentiation 1995 6 4 417 427
22. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D., Embryonic lethality and liver degeneration in mice lacking the RelA component of NF- κB Nature 1995 376 6536 167 170
23. Vanden Berghe W., Vermeulen L., Delerive P., De Bosscher K., Staels B., Haegeman G., A paradigm for gene regulation: inflammation, NF- κB and PPAR Advances in Experimental Medicine and Biology 2003 544 181 196
24. Maeda S., Omata M., Inflammation and cancer: role of nuclear factor-kappaB activation Cancer Science 2008 99 5 836 842
25. Sha W. C., Liou H.-C., Tuomanen E. I., Baltimore D., Targeted disruption of the p50 subunit of NF- κB leads to multifocal defects in immune responses Cell 1995 80 2 321 330
26. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D., Embryonic lethality and liver degeneration in mice lacking the RelA component of NF- κB Nature 1995 376 6536 167 170
27. Kontgen F., Grumont R. J., Strasser A., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression Genes & Development 1995 9 16 1965 1977
28. Franzoso G., Carlson L., Poljak L., Mice deficient in nuclear factor (NF)- κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture Journal of Experimental Medicine 1998 187 2 147 159
29. Weih F., Carrasco D., Durham S. K., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF- κB/Rel family Cell 1995 80 2 331 340
30. Pikarsky E., Porat R. M., Stein I., NF- κB functions as a tumour promoter in inflammation-associated cancer Nature 2004 431 7007 461 466
31. Sakurai T., Maeda S., Chang L., Karin M., Loss of hepatic NF- κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation Proceedings of the National Academy of Sciences of the United States of America 2006 103 28 10544 10551
32. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M., Suppression of TNF- α -induced apoptosis by NF- κB Science 1996 274 5288 787 789
33. Wang C.-Y., Mayo M. W., Baldwin A. S. Jr., TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF- κB Science 1996 274 5288 784 787
34. Beg A. A., Baltimore D., An essential role for NF- κB in preventing TNF- α -induced cell death Science 1996 274 5288 782 784
35. Schoemaker M. H., Ros J. E., Homan M., Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF- κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis Journal of Hepatology 2002 36 6 742 750
36. Xu Y., Bialik S., Jones B. E., NF- κB inactivation converts a hepatocyte cell line TNF- α response from proliferation to apoptosis American Journal of Physiology 1998 275 4, part 1 C1058 C1066
37. Lu Z., Lee E. Y., Robertson L. W., Glauert H. P., Spear B. T., Effect of 2, 2 ′,4, 4 ′,5, 5 ′ -hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF- κB Toxicological Sciences 2004 81 1 35 42
38. Tharappel J. C., Nalca A., Owens A. B., Cell proliferation and apoptosis are altered in mice deficient in the NF- κB p50 subunit after treatment with the peroxisome proliferator ciprofibrate Toxicological Sciences 2003 75 2 300 308
39. DeAngelis R. A., Kovalovich K., Cressman D. E., Taub R., Normal liver regeneration in p50/nuclear factor κB1 knockout mice Hepatology 2001 33 4 915 924
40. Chaisson M. L., Brooling J. T., Ladiges W., Tsai S., Fausto N., Hepatocyte-specific inhibition of NF- κB leads to apoptosis after TNF treatment, but not after partial hepatectomy Journal of Clinical Investigation 2002 110 2 193 202
41. Kato A., Edwards M. J., Lentsch A. B., Gene deletion of NF- κB p50 does not alter the hepatic inflammatory response to ischemia/reperfusion Journal of Hepatology 2002 37 1 48 55
42. Horwitz B. H., Zelazowski P., Shen Y., The p65 subunit of NF- κB is redundant with p50 during B cell proliferative responses, and is required for germline C H transcription and class switching to IgG3 The Journal of Immunology 1999 162 4 1941 1946
43. Snapper C. M., Zelazowski P., Rosas F. R., B cells from p50/NF- κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching The Journal of Immunology 1996 156 1 183 191
44. Snapper C. M., Rosas F. R., Zelazowski P., B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching Journal of Experimental Medicine 1996 184 4 1537 1541
45. Li Y., Leung L. K., Glauert H. P., Spear B. T., Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF- κB activity Carcinogenesis 1996 17 11 2305 2309
46. Costa R. H., Tronche R., Yaniv M., HNF3 protein family Liver Gene Expression 1994 New York, NY, USA R.G. Landes Company 183 205
47. Ohmura T., Ledda-Columbano G. M., Piga R., Hepatocyte proliferation induced by a single dose of a peroxisome proliferator American Journal of Pathology 1996 148 3 815 824
48. Menegazzi M., Carcereri-De Prati A., Suzuki H., Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF- κB and AP-1 or with expression of tumor necrosis factor α Hepatology 1997 25 3 585 592
49. Espandiari P., Ludewig G., Glauert H. P., Robertson L. W., Activation of hepatic NF- κB by the herbicide Dicamba (2-methoxy-3,6-dichlorobenzoic acid) in female and male rats Journal of Biochemical and Molecular Toxicology 1998 12 6 339 344
50. Rusyn I., Tsukamoto H., Thurman R. G., WY-14 643 rapidly activates nuclear factor κB in Kupffer cells before hepatocytes Carcinogenesis 1998 19 7 1217 1222
51. Rusyn I., Yamashina S., Segal B. H., Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators Cancer Research 2000 60 17 4798 4803
52. Delerive P., Gervois P., Fruchart J.-C., Staels B., Induction of I κB α expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor- α activators The Journal of Biological Chemistry 2000 275 47 36703 36707
53. Tharappel J. C., Cunningham M. L., Spear B. T., Glauert H. P., Differential activation of hepatic NF- κB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate Toxicological Sciences 2001 62 1 20 27
54. Fischer J. G., Glauert H. P., Yin T., Sweeney-Reeves M. L., Larmonier N., Black M. C., Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF- κB activation induced by the peroxisome proliferator, Wy-14,643 The Journal of Nutrition 2002 132 9 2525 2531
55. Nanji A. A., Dannenberg A. J., Jokelainen K., Bass N. M., Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator- α (PPAR α)-regulated genes and is ameliorated by PPAR α activation Journal of Pharmacology and Experimental Therapeutics 2004 310 1 417 424
56. Woods C. G., Burns A. M., Bradford B. U., WY-14,643-induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase Toxicological Sciences 2007 98 2 366 374
57. Calfee-Mason K. G., Lee E. Y., Spear B. T., Glauert H. P., Role of the p50 subunit of NF- κB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate Food and Chemical Toxicology 2008 46 6 2062 2073
58. Li Y., Glauert H. P., Spear B. T., NF κB activity is increased by the peroxisome proliferator ciprofibrate in rats Proceedings of the American Association of Cancer Research 1996 37 160
59. Neschen S., Moore I., Regittnig W., Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content American Journal of Physiology 2002 282 2 E395 E401
60. West D. A., James N. H., Cosulich S. C., Role for tumor necrosis factor α receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin Hepatology 1999 30 6 1417 1424
61. Kleemann R., Verschuren L., de Rooij B.-J., Evidence for anti-inflammatory activity of statins and PPAR α activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro Blood 2004 103 11 4188 4194
62. Cosulich S. C., James N. H., Needham M. R. C., Newham P. P., Bundell K. R., Roberts R. A., A dominant megative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin Carcinogenesis 2000 21 9 1757 1760
63. Glauert H. P., Eyigor A., Tharappel J. C., Cooper S., Lee E. Y., Spear B. T., Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF- κB in mice administered the peroxisome proliferator Wy-14,643 Toxicological Sciences 2006 90 2 331 336
64. Inoue I., Itoh F., Aoyagi S., Fibrate and statin synergistically increase the transcriptional activities of PPAR α /RXR α and decrease the transactivation of NF κB Biochemical and Biophysical Research Communications 2002 290 1 131 139
65. Delerive P., De Bosscher K., Besnard S., Peroxisome proliferator- activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF- κB and AP-1 The Journal of Biological Chemistry 1999 274 45 32048 32054
66. Marx N., Sukhova G. K., Collins T., Libby P., Plutzky J., PPAR α activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 1999 99 24 3125 3131
67. Staels B., Koenig W., Habib A., Activation of human aortic smooth-muscle cells is inhibited by PPAR α but not by PPAR γ activators Nature 1998 393 6687 790 793
68. Poynter M. E., Daynes R. A., Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor- κB signaling, and reduces inflammatory cytokine production in aging The Journal of Biological Chemistry 1998 273 49 32833 32841
69. Wunderlich F. T., Luedde T., Singer S., Hepatic NF- κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1297 1302
70. Li Y., Tharappel J. C., Cooper S., Glenn M., Glauert H. P., Spear B. T., Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF- κB DNA and Cell Biology 2000 19 2 113 120
71. Lake B. G., Evans J. G., Cunninghame M. E., Price R. J., Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster Environmental Health Perspectives 1993 101 supplement 5 241 247
72. Durnford J. M., Hejtmancik M. R., Kurtz P. J., Peroxisomal enzyme activity and cell proliferation in rats, mice and hamsters exposed for 13-weeks to Wy-14,643 and gemfibrozil Toxicological Sciences 1998 42 supplement 1 11
73. O'Brien M. L., Cunningham M. L., Spear B. T., Glauert H. P., Effects of peroxisome proliferators on glutathione and glutathione-related enzymes in rats and hamsters Toxicology and Applied Pharmacology 2001 171 1 27 37
74. O'Brien M. L., Twaroski T. P., Cunningham M. L., Glauert H. P., Spear B. T., Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters Toxicological Sciences 2001 60 2 271 278